1. Schmale H, Ivell R, Breindl M, Darmer D, Richter D. The mutant vasopressin gene from diabetes insipidus (Brattleboro) rats is transcribed but the message is not efficiently translated. EMBO J1984; 3: 3289–3293
2. Valtin H. Genetic models of diabetes insipidus. In: E.E. Windhager, ed. Handbook of Physiology. Oxford University Press, New York, 1992; 1281–1315
3. Kinter LB, Ilson BE, Caltabianol S et al. Antidiuretic hormone antagonism in humans: are there predictors? In: Jard S, Jamison R, ed. Vasopressin. INSERM/John Libbey Eurotext Ltd, Paris, London, 1991; 321–329
4. Yamamura Y, Ogawa H, Yamashita H et al. Characterization of a novel aquaretic agent, OPC‐31260, as an orally effective, non‐peptide vasopressin V2 receptor antagonist. Br J Pharmacol1992; 105: 787–791
5. Ohnishi A, Orita Y, Takagi N et al. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men. J Pharmacol Exp Ther1995; 272: 546–551